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Glucocorticoid-induced tumor necrosis factor receptor family-related protein (TNFRSF18,
CD357) is constitutively expressed on regulatoryT cells (Tregs) and is inducible on effector
T cells. In this report, we examine the role of glucocorticoid-induced TNF receptor family-
related protein ligand (GITR-L), which is expressed by antigen presenting cells, on the
development and expansion ofTregs. We found that GITR-L is dispensable for the develop-
ment of naturally occurring FoxP3+Treg cells in the thymus. However, the expansion ofTreg
in GITR-L−/− mice is impaired after injection of the dendritic cells (DCs) inducing factor Flt3
ligand. Furthermore, DCs from the liver of GITR-L−/− mice were less efficient in inducing
proliferation of antigen-specificTreg cells in vitro than the same cells from WT littermates.
Upon gene transfer of ovalbumin into hepatocytes of GITR-L−/−FoxP3(GFP) reporter mice
using adeno-associated virus (AAV8-OVA) the number of antigen-specific Treg in liver and
spleen is reduced. The reduced number of Tregs resulted in an increase in the number of
ovalbumin specific CD8+ T effector cells. This is highly significant because proliferation of
antigen-specific CD8+ cells itself is dependent on the presence of GITR-L, as shown by
in vitro experiments and by adoptive transfers into GITR-L−/−Rag−/− and Rag−/− mice that
had received AAV8-OVA. Surprisingly, administering αCD3 significantly reduced the num-
bers of FoxP3+ Treg cells in the liver and spleen of GITR-L−/− but not WT mice. Because
soluble Fc-GITR-L partially rescues αCD3 induced in vitro depletion of the CD103+ subset
of FoxP3+CD4+ Treg cells, we conclude that expression of GITR-L by antigen presenting
cells is requisite for optimalTreg-mediated regulation of immune responses including those
in response during gene transfer.
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INTRODUCTION
CD4+CD25+FoxP3+ regulatory T cells (Treg), which develop in
the thymus or can be induced in peripheral organs, control many
aspects of the immune response (1–4). Tregs constitutively express
glucocorticoid-induced tumor necrosis factor receptor family-
related protein (GITR, TNFRSF18, CD357), which is inducible on
effector T cells (Teffs) (2, 5–8). Using Fc-GITR-L, a soluble form of
the natural ligand of GITR, we found recently that glucocorticoid-
induced TNF receptor family-related protein ligand (GITR-L)
preferentially induces the in vivo and in vitro expansion of func-
tionally competent Tregs (9). Furthermore, a significantly higher
proportion of FoxP3+ Tregs is also found in GITR-L transgenic
mouse strains, in which the expression of GITR-L is under control
of the CD19- and MHC-II-promoter respectively (10, 11). GITR-
L is not expressed by T cells (8), but is found on plasmacytoid
dendritic cells (pDCs), Langerhans cells, macrophage subpopula-
tions, and endothelial cells (12–15). Here we use GITR-L−/− mice
to examine the role of GITR-L in the induction of Tregs and Treg-
mediated suppression in response to hepatic gene transfer with
the adeno-associated viral vector AAV8.
Tolerance induction to specific foreign protein by hepatic gene
transfer may be established in two steps. First, antigen-specific
Tregs are de novo induced in the hepatic microenvironment. Sec-
ond, antigen-specific Tregs are expanded systemically. Indeed, we
previously found that transgene product-specific Treg actively sup-
presses antibody and T cell responses thereby ensuring long-term
gene expression (16). Recently, studies in hemophilic mouse mod-
els have shown that AAV-mediated hepatic gene transfer can not
only prevent but also reverse pathogenic antibody responses and
desensitize from severe allergic reactions to the therapeutic coagu-
lation factor IX protein (17–20). We have recently shown that the
immune suppressive cytokine TGF-β is required for Treg induction
in hepatic AAV gene transfer and thus necessary for suppression of
antibody and CD8+ T cell responses against the transgene product
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(21). TGF-β, a cytokine highly expressed in mucosal tissues and
sites of inflammation, plays a role in conversion of conventional
peripheral CD4+ T cells into Treg, and TGF-β up-regulates expres-
sion of CD103 (Integrin αEβ7) (22), which is the primary ligand of
E-cadherin, an epithelial adhesion molecule. Expression of CD103
marks a subset of peripheral inducible Tregs (about 20–30% of the
CD4+FoxP3+ Tregs in the spleen), which inhibit graft-versus-host
disease more potently than the CD4+CD25+ Tregs (23, 24).
In this study, we provide evidence in support of the concept
that the interactions between GITR and GITR-L are requisite
for optimal functioning of Tregs. To this end, we analyze GITR-
L−/−FoxP3(GFP) and GITR-L−/−CX3CR1(GFP) mice after gene
transfer of ovalbumin into hepatocytes with adeno-associated
virus (AAV8-OVA). Coordinate expansion of Treg and dendritic
cells (DCs) was assessed after injection of Flt3 ligand in GITR-
L−/− mice. The interactions between antigen presenting cells and
Tregs are also evaluated after administering αCD3 in GITR-L−/−
mice or by co-activation with αCD3 and soluble Fc-GITR-L.
MATERIALS AND METHODS
MICE
B6, OT-II Tg, and CX3CR1(GFP) reporter mice were purchased
from the Jackson Laboratory (Bar Harbor, ME, USA). OT-
I×Rag-/- mice were purchased from Taconic Labs (German-
town, NY, USA). GITR-L-/- and FoxP3-IRES-EGFP-SV40 knock-in
[FoxP3(GFP)] B6 mice were described previously (8, 25). GITR-
L-/- mice were crossed with FoxP3(GFP) and CX3CR1(GFP) mice
to generate GITR-L-/-FoxP3(GFP) and GITR-L-/-CX3CR1(GFP)
B6 mice. All animals were housed in the Center for Life Sci-
ence animal facility of BIDMC. The Guide for the Care and Use
of Laboratory Animals was followed in the conduct of the ani-
mal studies of the Institutional Animal Care and Use Committee
at BIDMC. Veterinary care was given to any animals requiring
medical attention.
ANTIBODIES
Anti-CD11b-PacBlu, αCD11b-FITC, αCD4-PE, αCD4-APC,
αCD11c-APC,αCD11c-PE,αTCRvα2-PE, and αCD3ε(145-2C11)
were purchased from BioLegend (San Diego, CA, USA). Anti-
Ly6C-PerCP and αFoxP3-APC were products of eBioscience
(San Jose, CA, USA). Anti-Ly6G-PE, αNK1.1-PE, αCD8α-PacBlu,
αCD25-PE, and αCD103-Alexa Fluor 647 were products from
BD Biosciences (San Jose, CA, USA). Flt3L-Fc fusion protein
was purchased from BioXCell (West Lebanon, NH, USA). Anti-
IL-2 was purchased from R&D Systems (Minneapolis, MN,
USA). Fc-GITR-L fusion protein was produced as described
previously (9).
AAV8-OVA MEDIATED EXPRESSION OF FOREIGN PROTEIN IN
HEPATOCYTES
AAV8-OVA vector (containing an ovalbumin expression cas-
sette driven by AAV-EF1α) was packaged into serotype 8 cap-
sid as described previously (16). Vector was injected i.v. into
FoxP3(GFP) and GITR-L-/-FoxP3(GFP) mice at a dose of 1010 vec-
tor genome/mouse. Five weeks later, leukocytes from liver, spleen,
and thymus were stained with TCRvα2.
Also, Ly6G-NK1.1-GFP+ cells FACS sorted from the liver of
CX3CR1(GFP) mice 7 days after AAV8-OVA injection were incu-
bated with OT-II CD4+ or CFSE-labeled OT-I CD8+ T cells for
3 days. OT-II CD4+ T cell cultures were stained with TCRvα2 and
FoxP3. OT-I CD8+ T cell culture was stained with TCRvα2 and
proliferating CD8+ cells were evaluated by CFSE dilution.
INDUCTION OF DENDRITIC CELLS AND TREG WITH Flt3L
Flt3L-Fc fusion protein (10 ng/mouse/injection) was i.p. injected
into FoxP3(GFP) and GITR-L-/-FoxP3(GFP) mice for nine con-
secutive days as described previously (26). Leukocytes from the
spleen and liver were analyzed at day 10.
CELLULARITY IN MICE AFTER αCD3-MEDIATED ACTIVATION OF T CELLS
BY IN VIVO
Anti-CD3ε was i.p. injected into CX3CR1(GFP) and GITR-
L−/−CX3CR1(GFP) mice (20µg/mouse, one injection). After
72 h, leukocytes of the spleen and liver were stained with CD4
and FoxP3. CX3CR1+ cells were evaluated by expression of the
reporter gene GFP.
IN VITRO ACTIVATION OF CD4+ T CELLS
CD4+ T cells from the spleen of FoxP3(GFP) mice were nega-
tively selected using a CD4+ T cells isolation kit (Miltenyi,Auburn,
CA, USA) and were activated with αCD3-coupled microbeads in
a round bottom 96-well plate in the presence or absence of Fc-
GITR-L (1µg/ml) for 2 days as described previously (9). Cells were
stained with CD4 and CD103. Expression of FoxP3 was judged by
the reporter protein EGFP. Cell numbers were counted with a
Countess Automated Cell Counter (Invitrogen, Grand Island, NY,
USA).
ISOLATION OF LIVER LEUKOCYTES
Liver leukocytes were isolated as described previously (27). Briefly,
liver was mashed and filtered through a 70µM cell strainer. Hepa-
tocytes and cell debris were removed by spinning at 300 rpm for
10 min. Supernatant was centrifuged at 1500 rpm for 10 min to
collect cells. Leukocytes were isolated from the interface of a 40
and 70% Percoll gradient.
Statistical analysis used Prism 4.0c software (GraphPad, San
Diego, CA, USA). Statistical comparisons were performed using
the two-tailed Student’s t -test. Values of P < 0.05 were considered
to be statistically significant.
RESULTS
Flt3L-INDUCED EXPANSION OF TREG WAS IMPAIRED IN GITR-L
DEFICIENT MICE DUE TO A PARTIALLY REDUCED NUMBER OF
DENDRITIC CELL SUBPOPULATIONS
We previously found that after administering a Fc-GITR-L fusion
protein to WT mice the number of Treg cells increased, which
was confirmed by studies with GITR-L transgenic mice (9–11,
28). Surprisingly, we found that GITR-L was dispensable for
the development of naturally occurring Treg, as the number of
FoxP3+ Treg cells was normal in the thymus and spleen of GITR-
L−/−FoxP3(GFP) mice under resting conditions (Figure 1A;
Figure S1 in Supplementary Material).
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FIGURE 1 | Flt3L-induced expansion ofTreg. Flt3L-Fc fusion protein was
injected into FoxP3(GFP) and GITR-L−/−FoxP3(GFP) mice (10 ng/mouse/
injection, nine injections). CD4+CD8− T cells from the thymus, spleen,
and/or liver were analyzed by FACS for FoxP3 expression based on the
expression of reporter protein EGFP. (A) Percentages of CD4+FoxP3+ Treg
in the thymus and spleen of FoxP3(GFP) and GITR-L−/−FoxP3(GFP) mice
without stimulation. Percentages (B) and representative staining (C) of Treg
in the spleen and liver after administering Flt3L. (D) Number of CD4+ T cells
in the spleen and liver of FoxP3(GFP) and GITR-L−/−FoxP3(GFP) mice after
administering Flt3L. Filled circle represents FoxP3(GFP) mouse. Open
circle represents GITR-L−/−FoxP3(GFP) mouse. Each circle represents one
mouse.
To further investigate the role of GITR-L in controlling Treg
development, we assessed the consequences of injecting Fms-
related tyrosine kinase 3 ligand (Flt3L) into FoxP3(GFP) and
GITR-L−/−FoxP3(GFP) mice for nine consecutive days. Not only
is Flt3L a potent inducer of DC and macrophage proliferation (26,
29), several phagocyte subpopulations express GITR-L (12, 30).
After the injection of Fc-Flt3L fusion protein, both the numbers
and the frequency of FoxP3+ Treg were significantly increased
in the spleen and liver. This Fc-Flt3L-induced expansion was,
however, significantly reduced in GITR-L−/−FoxP3(GFP) mice
(Figures 1B,C). The total number of CD4+ T cells in the spleen
was also lower in GITR-L−/−FoxP3(GFP) mice than the WT coun-
terparts (Figure 1D). Thus, GITR-L plays a significant role in the
expansion of Treg in the peripheral tissues.
We next evaluated whether the impaired Flt3L-induced expan-
sion of Treg cells in GITR-L−/−FoxP3(GFP) mice correlated with
reduced numbers of DCs and macrophages (MØ) (31, 32). As
shown in Figure 2A and Figure S2A in Supplementary Mater-
ial, the percentage of CD11c+CD11b+ and CD11c+CD11b− DCs
was reduced in the spleen of GITR-L−/−FoxP3(GFP) mice as com-
pared to FoxP3(GFP) mice. Although the number of conventional
CD11c+ DCs in the liver was normal (Figure 2A), the percentage
of pDCs in GITR-L−/−FoxP3(GFP) mice was higher than that of
their WT counterparts (Figure 2B; Figure S2B in Supplementary
FIGURE 2 | CD11c+ DCs after Flt3L induction. Flt3L-Fc fusion protein was
injected into FoxP3(GFP) and GITR-L−/−FoxP3(GFP) mice as described in
Figure 1. Different subsets of myeloid cells in the spleen and liver were
analyzed. (A) Percentages of CD11c+ cells in the spleen and liver.
(B) Percentages of CD11c+PDCA1+ cells in the spleen and liver.
(C) Percentages of CD11c−CD11b+ cells. Filled circle represents
FoxP3(GFP) mouse. Open circle represents GITR-L−/−FoxP3(GFP) mouse.
Each circle represents one mouse.
Material and Data not shown). The frequency of CD11c−CD11b+
MØ was comparable between these two mice (Figure 2C). Taken
together, these data indicate that after Flt3L induction, GITR-L
affects the expansion and differentiation of subpopulations of
DCs, which in turn leads to expansion of Tregs.
GITR-L−/− CX3CR1+ DCs ISOLATED FROM THE LIVER ARE LESS
EFFICIENT THANWT CX3CR1+ DCs IN THE IN VITRO INDUCTION OF
OVA-SPECIFIC TREG AND CD8+ T CELLS
To directly test whether the absence of GITR-L in DC sub-
populations affects proliferation of antigen-specific GITR+ Treg
and CD8+ cells, we immunized GITR-L−/−CX3CR1(GFP) and
WT CX3CR1(GFP) mice by gene transfer with AAV8-OVA
(Figure 3A). One week after injection of AAV8-OVA, liver
CX3CR1(GFP)+ cells purified by FACS were incubated with OVA-
specific OT-II CD4+ T cells or OT-I CD8+ cells for 3 days.
GITR-L−/− CX3CR1+ cells were less efficient in inducing Treg as
compared to the same cells isolated from WT mice (Figures 3B,C).
Since activated CD8+ cells carry GITR on their surface, we also
evaluated whether in vitro proliferation of CD8+ T cells would be
affected by the absence of GITR-L from the surface of these DCs.
Indeed, the proliferation of CD8+ OT-I cells was reduced when
cocultured with liver CX3CR1+ cells from AAV8-OVA-primed
GITR-L−/−CX3CR1(GFP) mice compared to OT-I cells cultured
with WT CX3CR1+ DCs (Figures 3D,E).
We conclude that GITR-L on the surface of antigen presenting
cells can drive proliferation of both FoxP3+CD4+ Treg cells and
activated CD8+ T cells in an antigen-specific manner.
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FIGURE 3 | In vitro induction of OVA-specificTreg and CD8+ T cells with
hepatic CX3CR1+ DCs. (A) Schematic for in vitro priming of CD8+ OT-I and
CD4+ OT-II T cells. Briefly, AAV8-OVA(1010 vector genome/mouse) was i.v.
injected into CX3CR1(GFP) and GITR-L−/−CX3CR1(GFP) mice. After 7 days,
Ly6G-NK1.1-CX3CR1(GFP)+ cells were purified from the liver and incubated
with CD8+ OT-I T and CD4+ OT-II T cells at different ratios for 3 days.
Divisions of CD8+ OT-I T cells were evaluated by CFSE dilution.
(B) Percentages of in vitro induced of TCRvα2+FoxP3+ Treg.
(C) Representative stainings of (B). (D) Ratios of proliferating
TCRvα2+CD8+ OT-I T cells. (E) Representative staining of (D). Results
represent one of three independent experiments. Error bars indicate
mean±SEM of triplicates.
AFTER AAV8-OVA GENE TRANSFER, THE NUMBER OF
ANTIGEN-SPECIFIC TREG IN GITR-L−/−FoxP3 MICE IS REDUCED, WHICH
RESULTS IN AN INCREASED NUMBER OF OVA-SPECIFIC CD8+ T CELLS
Because targeted expression of exogenous protein in hepatocytes
by AAV8-mediated gene transfer induces a Treg-mediated toler-
ance (16), we assessed whether this process involves GITR-L. To
assess this, we injected an AAV8-OVA vector into in FoxP3(GFP)
and GITR-L−/−FoxP3(GFP) mice and determined the number of
OVA-specific Treg and CD8+ T cells. Consistent with the results
when administering Flt3L, there was a reduced percentage of
OVA-specific FoxP3+TCRvα2+ T cells in the spleen and liver of
GITR-L−/−FoxP3(GFP) mice as compared to that of WT mice
5 weeks after vector administration (Figure 4A). Conversely, AAV-
mediated OVA expression in the hepatocytes induced an increased
percentage of OVA-specific CD8+TCRvα2+ T cells in the spleen
and liver of GITR-L−/−FoxP3(GFP) mice (Figure 4B). By contrast,
the total cell numbers were comparable between these two mouse
strains (Figure 4C). The data suggest that GITR-L deficiency may
FIGURE 4 | In vivo induction of OVA-specificTreg and CD8+ T cells in
GITR-L−/−FoxP3(GFP) mice. AAV8-OVA (1010 vector genome/mouse) was
i.v. injected into FoxP3(GFP) and GITR-L−/−FoxP3(GFP) mice. Five weeks
later, leukocytes from the liver and spleen were stained with TCRvα2.
(A) Percentages of FoxP3+/TCRvα2+ cells. (B) Percentages of
TCRvα2+/CD8+ cells. (C) Number of leukocytes. Filled circle represents
FoxP3(GFP) mouse. Filled circle represents FoxP3(GFP) mouse. Open circle
represents GITR-L−/−FoxP3(GFP) mouse. Each circle represents one mouse.
impair the induction of antigen-specific Tregs (16–18, 21, 33),
which may at least partially compromise their immunosuppressive
capability.
As the in vitro data suggest that GITR-L expression on DCs
causes the expansion of CD8+ cells, this in vivo result might under-
estimate the consequences of the reduced number of the Tregs in
the GITR-L−/− mice. To test whether GITR-L is implicated in
the in vivo expansion of antigen-specific CD8+ cells, we used a
system in which the Treg-mediated suppression is absent. To this
end, we injected AAV8-OVA into Rag−/− and GITR-L−/−Rag−/−
mice followed by the adoptive transfer of OT-I CD8+ T cells after
1 week (Figure 5A). Eight weeks after transfer of OT-I CD8+ T
cells, the number of CD8+ T cells in the blood of the GITR-
L−/−Rag−/− recipients was significantly lower than that of the
Rag−/− recipients (Figure 5B). This was not due to an inadequate
amount of OVA antigen production in the GITR-L−/−Rag−/−
recipients (Figure 5C). Taken together, the data indicate that
GITR-L is required for optimal induction and/or expansion of
antigen-specific Treg in the context of hepatic AAV8 gene transfer.
DEPLETION OF CX3CR1+ (GFP) CELLS BY αCD3 IN GITR-L−/− MICE
CORRELATES WITH A REDUCED NUMBER OF FoxP3+ TREG CELLS
In vitro expansion of FoxP3+ Treg cells can be achieved by stim-
ulation with a combination of αCD3 and soluble GITR-L (Fc-
GITR-L) (9). We then assessed whether injection of αCD3 into
WT and GITR-L−/− mice would affect the Treg population. As
shown in Figures 6A,B, αCD3 induced a significant reduction of
the percentage of FoxP3+ Treg in the spleen and liver of GITR-
L−/−CX3CR1(GFP) mice, but not in WT CX3CR1(GFP) mice. In
support of our observations in this paper, the reduced number of
Tregs coincided with a reduction of CX3CR1+ DCs in the spleen
Frontiers in Immunology | Microbial Immunology February 2014 | Volume 5 | Article 35 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liao et al. GITR-L promotes Treg-mediated suppression
FIGURE 5 | In vivo induction of OVA-specific CD8+ T cells in
GITR-L−/−Rag−/− mice. (A) Schematic for in vivo expansion of CD8+ OT-I T
cells. Briefly, AAV8-OVA (1010 vector genome/mouse) vector was i.v.
injected to Rag−/− or GITR-L−/−Rag−/− mice. Seven days later, CD8+ OT-I T
cells (106 cells/mouse) were i.p. injected to mice with AAV8-OVA gene
transfer. Mice were euthanized after 8 weeks. (B) Percentages of CD8+ T
cells in the blood were evaluated by FACS. (C) Concentrations of chicken
ovabulmin protein in the plasma were measured by ELISA. Filled circle
represents Rag−/− mouse. Open circle represents GITR-L−/−Rag−/− mouse.
Each circle represents one mouse.
and liver of GITR-L−/−CX3CR1(GFP) mice (Figures 6C,D). In
contrast, the numbers of CX3CR1+ cells in the spleen and liver
were comparable in the two mouse strains under homeostasis
(Figure S3 in Supplementary Material).
To further investigate the role of GITR-L in the expansion
of FoxP3+ Treg, CD4+ T cells were purified from the spleen of
FoxP3(GFP) mice and stimulated in vitro with αCD3 with either
Fc-GITR-L or IgG. Forty-eight hours after exposure to αCD3,
the number of total CD4+ and FoxP3+CD4+ Treg was signif-
icantly higher in the presence of Fc-GITR-L than that of IgG
(Figures 7A,B). Interestingly, a subset of CD103+ Treg cells, which
is induced in epithelium and in sites of inflammation (23, 34)
and comprises approximately 20% of all FoxP3+ Treg cells in the
spleen, was also expanded by Fc-GITR-L (Figures 7C,D).
We conclude that while the induction or expansion of Treg is
impaired in the absence of GITR-L, Fc-GITR-L provides a positive
signal to GITR+ Treg.
DISCUSSION
The receptor-ligand pair GITR/GITR-L (TNFRSF18/TNFSF18)
appears to be involved in the development of a variety of
inflammation-related diseases in murine models (6, 8, 12, 35, 36).
It was originally thought that the suppressor function of Treg
cells, which constitutively express GITR, would be abrogated by
anti-GITR thus breaking immune self-tolerance (2). More recent
additional evidence shows that GITR engagement by its natural
ligand GITR-L causes an extensive expansion of functionally com-
petent Tregs (9–11), although the relative role of GITR on Treg
and Teff cells remains only partly understood. In this study we find
that in the absence of GITR-L the expansion of FoxP3+ Treg cells is
FIGURE 6 | Numbers ofTreg and CX3CR1+ DCs after administering
αCD3. Anti-CD3ε (20µg/mouse, one injection) was i.p. injected into
CX3CR1(GFP) and GITR-L−/−CX3CR1(GFP) mice. Mice were euthanized at
day 3. Splenocytes and liver leukocytes were stained for the expression of
CD4 and FoxP3 by FACS. CX3CR1+ cells were assessed by the expression
of reporter protein EGFP. Percentages (A) and representative staining (B) of
FoxP3+CD4+ Treg cells in the spleen and liver. Percentages (C) and
representative staining (D) of CX3CR1+ phagocytes in splenocytes and liver
leukocytes. Filled circle represents CX3CR1(GFP) mouse. Open circle
represents GITR-L−/−CX3CR1(GFP) mouse. Each circle represents one
mouse.
impaired in an antigen-specific manner, which can be mimicked by
in vivo and in vitro activation of CD4+ Treg cells with αCD3. Our
results are consistent with the findings of the Chatila group that
expansion and contraction of Teff and Treg dynamically control
primary immune responses to foreign antigen (25).
Glucocorticoid-induced TNF receptor family-related protein
ligand impacts immune regulation in gene replacement therapy
at least at three levels. First, the induction/expansion of antigen-
specific Treg cells in the liver after AAV-mediated gene therapy is
impaired directly by the absence of GITR-L. Second, the expansion
of antigen-specific CD8+ T cells is reduced by GITR-L deficiency.
However, impaired expansion of Treg cells can on the other hand
up-regulate CD8+ T cell expansion indirectly. Third, GITR-L defi-
ciency affects the infiltration of monocyte-derived MØ to the sites
where exogenous protein is expressed and/or the sites of inflam-
mation (30), which changes the local function of different immune
cells. These GITR-L-expressing, monocyte-derived MØ may pro-
vide a microenvironment for the expression of CD103 in Treg cells,
an integrin that facilitates the retention of Treg cells in the sites of
inflammation or infection.
Surprisingly, we found that administering αCD3 causes the
depletion of CX3CR1+ DCs in the spleen and liver of GITR-L−/−
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FIGURE 7 | Expansion of FoxP3+ and CD103+ Tregs by Fc-GITR-L
in vitro. CD4+ T cells (105 cells/well) from the spleen of FoxP3(GFP) mice
were stimulated with αCD3-beads in the presence of Fc-GITR-L or control
IgG for 2 days and then stained with CD4 and CD103. FoxP3 expression was
judged according to the expression of reporter protein EGFP. (A) Number of
total CD4+ cells. (B) Number of FoxP3+CD4+ Tregs. (C) Percentages of
CD103+ cells among gated FoxP3+ Tregs. (D) Representative staining of
(C). Results were representative of at least three independent
experiments. Error bars indicate mean±SEM of triplicates.
mice, which correlates with a reduced number of FoxP3+ Tregs.
It is reported that IL10-secreting GITR+ Tr1 cells may suppress
immune responses by granzyme B-mediated killing of myeloid
APCs (37, 38). Granzyme B is also important for the ability of
Treg, NK cells, and CD8+ T cells to kill their targets (39). It is pos-
sible that Tr1, Treg, and CD8+ T cells play a role in the depletion
of CX3CR1+ DCs in GITR-L−/− mice. In the presence of GITR-L,
an increased expansion of Treg may inhibit this self-destructive
cytotoxicity. Depletion of CX3CR1+ DCs, which includes the
GITR-L-expressing pDCs and MØ (12, 30), may feedback to cause
the reduction of Treg number during immune responses.
Ly6Chi monocytes give rise to CX3CR1+ DCs under both
steady state and inflammation. Under resting conditions,
CX3CR1+ DCs in the intestine is reported to induce a immuno-
suppressive CD8+ T cells (40). CX3CR1+ DCs isolated from the
liver are able to induce Treg in vitro. However, during inflamma-
tion CX3CR1+ DCs give rise to proinflammatory effector cells
(41). The mechanism how this Ly6Chi monocyte-derived DC
subpopulation is educated to be either protagonist or antago-
nist is still not well understood. Anti-CD3-mediated depletion
of CX3CR1+ DCs in the liver may provide an important tool for
the study of migration, colonization, and education of this special
DC subset (30).
In conclusion, our data show that GITR and GITR-L have
important implications for gene therapy. Optimal induction of
an immune regulatory response, which is crucial for tolerance to
the transgene product and for immune modulatory gene therapy,
requires co-stimulation by GITR-L, which enhances Treg induc-
tion and function. Expression of GITR-L on hepatic APCs may
in part explain the tolerogenic/Treg inducing capacity of hepatic
gene transfer.
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